• Powered by Crown Equity Holdings Inc.
      • crown-logo

        Crown Equity Holdings Inc. is publicly traded with the symbol CRWE. The Company primarily provides and offers advertising, branding, marketing solutions and services to boost customer awareness, as well as merchant visibility as a worldwide online multi-media publisher. For list of services offered click here

Post on CRWE World Login
logo Ashburn, UNITED STATES
header-img
  • Home
  • News
  • World
      • World News
      • Español
  • Politics
      • U.S. Legislators
      • Political News
  • Sports
  • Business
      • Markets
      • Hottest Stocks Today
      • CRWEWorld Stocks
      • Blockchain
      • Regulatory
      • Accounting
      • Fundraising Campaigns
      • IPOs
      • Money
      • Career
  • Tech
      • Tech
      • Science
  • Living
      • Arts & Entertainment
      • Family
      • Food
      • Pets
      • Seniors
      • Fashion/Fitness
      • Home & Garden
  • Health
      • Health
      • Pharma & Biotech
  • Opinion
      • Finance
      • Law
      • Healthcare
      • Cannabidiol (CBD)
      • Fashion
      • Podcasts
      • Tech
      • Music
  • Travel
  • Local
      • News
      • Trending Now
      • Real Estate
      • Coupons & Deals
      • Business Directory
  • Jobs
  • More
      • Business 2 Business
      • Press Releases
      • Press Releases Pricing
      • News from GlobeNewswire
      • News from PR Newswire
      • News from Business Wire
      • News from Accesswire
      • Video Channels
      • Beauty
      • Business
      • Comedy
      • Entertainment
      • Fashion
      • Featured
      • Health
      • Instructional
      • News
      • Politics
      • Sports
      • Technology
      • Entertainment
      • Horoscope
      • Sudoku
      • Crossword
      • Games
      • Chat
      • Affiliate | How It Works
      • Join CRWE WORLD Affiliate Program
      • CRWE WORLD Advertising Services Rate
      • Crown Equity Holdings' Overview
      • CRWEWorld Real-Time Global Visitors
      • Content Delivery Solution
        • Contact Us
  • More

Change City


-- OR --
load
load
/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/reef2.png
/assets/img/red-line.jpg
/assets/img/reef.png
  • Home
  • Articles
  • News Provided by PR Newswire
21ьз╕ Cweather-icon
/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/reef2.png
/assets/img/red-line.jpg
/assets/img/reef.png

ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders

News Provided by PR Newswire2018-06-28
21 Views

ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders

 
[28-June-2018]
 

ProMIS' shareholders show overwhelming support for all resolutions

TSX:PMN; OTCQB: ARFXF

TORONTO and CAMBRIDGE, MA, June 28, 2018 /PRNewswire/ - ProMIS Neurosciences, Inc. (the "Corporation"), a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced the voting results of the Corporation's annual meeting of shareholders held on June 27, 2018 in Toronto, Ontario, Canada (the "Meeting").

ProMIS Neurosciences Inc. (CNW Group/ProMIS Neurosciences Inc.)

The Corporation is pleased to announce that all of the resolutions announced in the Management Proxy Circular and placed before the Meeting were overwhelmingly approved by the shareholders. The total number of common shares represented by shareholders present in person or by proxy at the meeting was 86,988,509, representing 35.4% of the Corporation's outstanding common shares. A total of 86,773,839 common shares were represented by proxy and 214,670 common shares were represented by shareholders present in person.

"Today's Annual General Meeting marks the third anniversary of ProMIS Neurosciences" stated Eugene Williams, ProMIS Executive Chairman. "On behalf of the Board of Directors and the ProMIS management team I would like to sincerely thank our shareholders for their on-going support and look forward to continued progress addressing neurodegenerative diseases."

In particular, the following are the voting results for the 86,773,839 common shares that were voted in person or by proxy at the Meeting.

  • The following directors were elected, with each nominee receiving more than 75% of the votes cast:

DIRECTOR

FOR

WITHHELD

Neil Cashman, M.D.

85,285,559

1,702,950

Elliot Goldstein, M.D.

80,434,204

6,554,305

Patrick D. Kirwin

84,580,179

2,408,330

Johannes Roth

66,620,993

20,367,516

Eugene Williams

80,427,424

6,561,085

William Wyman

83,952,679

3,035,830

Richard J. Gregory, PH.D.

84,325,959

2,662,550

Anthony Giovinazzo, C. DIR., A.C.C.

68,216,813

18,771,696

 

  • PricewaterhouseCoopers, Chartered Professional Accountants, were appointed auditor of the Corporation. Shares voted in person and by proxies received represented 85,164,959 votes FOR and 1,823,550 votes WITHHELD

  • The resolution to continue the stock option plan was passed by a majority vote of the disinterested shareholders. There were 76,742,163 common shares voted FOR the resolution and 10,031,676 common shares voted AGAINST the resolution. The 27,340,220 common shares held by Insiders of the Corporation were excluded from and not counted in the vote tally.

For more details on the matters discussed at the Meeting, please refer to the Corporation's Management Proxy Circular, a copy of which is available under the Corporation's profile at www.sedar.com .

About ProMIS Neurosciences Inc.

ProMIS Neurosciences is a development stage biotechnology company focused on discovering and developing precision medicine therapeutics to treat neurodegenerative diseases, in particular Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). The Company's proprietary target discovery engine is based on the use of two complementary techniques. The Company applies its thermodynamic, computational discovery platform—ProMIS™ and Collective Coordinates — to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Using this unique precision medicine approach, the Company is developing novel antibody therapeutics for AD, ALS and PD.  ProMIS is headquartered in Toronto, Ontario, with offices in Cambridge, Massachusetts. ProMIS is listed on the Toronto Stock Exchange under the symbol PMN.TO, and on the OTCQB Venture Market under the symbol ARFXF.

For further information please consult the Company's website at:  www.promisneurosciences.com

Follow us on Twitter
Like us on LinkedIn

Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.  This news release contains certain "forward-looking statements" within the meaning of Canadian securities legislation. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects", "plans", "anticipates", believes", "intends", "estimates", "projects", "aims", "potential", "goal", "objective", "prospective", and similar expressions, or that events or conditions "will", "would", "may", "can", "could" or "should" occur. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except as required by the securities disclosure laws and regulations applicable to the Company, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change

The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/promis-neurosciences-announces-results-of-annual-meeting-of-shareholders-300673786.html

SOURCE ProMIS Neurosciences Inc.


Company Codes: OTC-QB:ARFXF, Toronto:PMN


© 2018 PR Newswire. All Rights Reserved.

#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.


XPeng (NYSE: XPEV) Unveils Beta Version Navigation Guided Pilot Function





/assets/img/cw-stocks.png

/assets/img/wysh-jewels.png

/assets/img/hjli.png

/assets/img/Mars-Parachute-2.png

/assets/img/crweworld-podcast.jpg
Sponsored
Also read
ROSEN, LEADING GLOBAL INVESTOR COUNSEL, Reminds QuantumScape Corporation Investors of Important March 8 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - QS
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds CD Projekt S.A. Investors of Important February 22 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm - OTGLY, OTGLF
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Splunk Inc. Investors of Important Deadline in Securities Class Action - SPLK
Alimentation Couche-Tard to Host Conference Call
Joint Announcement Between Alimentation Couche-Tard and Carrefour
ROSEN, A TOP RANKED LAW FIRM, Reminds Sona Nanotech Inc. Investors of Important February 16 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm - SNANF
Global Gas Chromatography Market : Growing demand for chromatography instruments in emerging markets
Global IV Equipment Market : APAC is expected to grow at the highest CAGR during the forecast period


Post on CRWE WorldSign Up for Free E-mail Updates
  • Real Estate Eagle Firm, Real Estate
Signup for free email updates
/assets/img/wall-street-rect2.png
/assets/img/wall-street-sq.png



Join with us
Live Traffic Feed
About CrweWorld
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Finance Disclaimer
  • Jobs
Subscribe for newsletter
3+2
Contact Info
  • contact@crweworld.com

  • P: (702) 683-8946

  • P: (702) 810-0178

  • 11226 Pentland Downs St, Las Vegas, NV 89141

Tweets by CrweWorld
Tweets by @CrweWorld
  • © 2021 crweworld.com
ad1

/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

/assets/images/ad/content-delivery-solution.jpg

 

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure

CLICK HERE FOR MORE INFORMATION

ad3

/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

/assets/images/ad/crwetube.png

Share your videos. Upload your videos for free on CRWETube

www.CRWETube.com

ad5

/assets/images/ad/ad4.png

 

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

Advertisements

/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

/assets/images/ad/content-delivery-solution.jpg

 

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure

CLICK HERE FOR MORE INFORMATION

/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

/assets/images/ad/crwetube.png

Share your videos. Upload your videos for free on CRWETube

www.CRWETube.com

/assets/images/ad/ad4.png

 

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

CRWE WORLD Advertising Services RateJoin CRWE WORLD Affiliate Program